
Al W. Girotti, PhD
Emeritus Professor
Locations
- Biochemistry
BSB 359
Contact Information
Education
BS, Massachusetts Institute of Technology, 1959
Biography
Dr. Girotti received his Bachelor of Science degree in Biology from Massachusetts Institute of Technology in 1959 and his Doctorate degree in Biochemistry from the University of Massachusetts, Amherst in 1965. He was a Postdoctoral Research Associate at Cornell University Medical College (1965-1968) where he investigated the role of metal ions in ribonuclease activity. Dr. Girotti joined the faculty of the Biochemistry Department at the 91ɫƵ in 1968.
Research Interests
Aerobic cells may experience oxidative stress damage if their enzymatic and non-enzymatic antioxidant defenses are overwhelmed by reactive oxygen species (ROS) generated by various endogenous and exogenous challenges. Unsaturated lipids in cell membranes and lipoproteins are prominent targets of ROS attack, undergoing peroxidative degradation with numerous structurally and functionally disruptive effects. Examples of free radical and non-radical ROS are shown in Scheme 1.
Among the many intermediates/products of lipid peroxidation, hydroperoxide species (LOOHs) are of special interest because of their relatively long lifetimes compared with free radical precursors or products. Under redox-constrained conditions, LOOHs can accumulate steadily with stress duration and may perturb membrane structure/function because of their relatively polar nature. However, in the presence of reductants and catalytic iron, LOOHs can undergo one-electron reduction with formation of oxyl (LO·) and epoxyallylic peroxyl (OLOO·) radicals, which exacerbate membrane damage by triggering chain peroxidation reactions (Scheme 1). Counteracting this is two-electron reductive detoxification catalyzed, for example, by glutathione-dependent selenoperoxidases, GPx4 (also known as PHGPx) being the most prominent isotype. Other LOOH pathways include inter-lipid transesterification and inter-membrane or membrane-lipoprotein translocation.
The Girotti group specializes in LOOH formation, turnover, and redox signaling activity, the latter currently attracting widespread biological and biomedical interest. Relatively low LOOH pressure may signal for upregulation of antioxidant proteins and activation of pro-growth transcription factors, whereas high LOOH pressure can signal for growth cessation and programmed cell death (apoptosis). Ongoing projects in the Girotti laboratory include the following: (a) Selenoperoxidase-mediated LOOH metabolism and how this modulates the pathologic as well as therapeutic effects of oxidative stress - as in antitumor photodynamic therapy (PDT), for example; (b) the biological ramifications of spontaneous or transfer protein-facilitated LOOH translocation between membranes or membranes and lipoproteins; pioneering studies of this phenomenon were carried out in the Girotti laboratory; (c) Protective effects of nitric oxide (NO) against cancer cell killing by PDT. Depending on its generation rate and location in cells, nitric oxide synthase (NOS)-derived NO can either be cytotoxic or cytoprotective (Scheme 2). In the latter category, our work has revealed that NO can (i) scavenge lipid-derived free radicals, (ii) induce antioxidant proteins such as heme oxygenase-1 and ferritin, or (iii) engage pro-survival/pro-growth signaling pathways that can compromise the effectiveness of PDT.
Publications
-
(Girotti AW, Korytowski W.) Cell Biochem Biophys. 2020 Jun;78(2):149-156 PMID: 32303898 SCOPUS ID: 2-s2.0-85083557731 04/19/2020
-
(Girotti AW, Fahey JM.) Biochem Pharmacol. 2020 Jun;176:113750 PMID: 31836386 PMCID: PMC7263973 SCOPUS ID: 2-s2.0-85076834169 12/15/2019
-
(Girotti AW.) Photochem Photobiol. 2020 May;96(3):500-505 PMID: 31545517 PMCID: PMC7085955 SCOPUS ID: 2-s2.0-85075187882 09/24/2019
-
(Bazak J, Korytowski W, Girotti AW.) Cancers (Basel). 2019 Oct 28;11(11) PMID: 31661869 PMCID: PMC6895962 10/31/2019
-
(Fahey JM, Korytowski W, Girotti AW.) Free Radic Biol Med. 2019 Jun;137:37-45 PMID: 30991141 PMCID: PMC6526063 SCOPUS ID: 2-s2.0-85062414767 04/17/2019
-
(Fahey JM, Girotti AW.) Cancers (Basel). 2019 Feb 15;11(2) PMID: 30781428 PMCID: PMC6406633 02/20/2019
-
(Girotti AW, Korytowski W.) Photochem Photobiol. 2019 Jan;95(1):73-82 PMID: 29962109 PMCID: PMC6312749 SCOPUS ID: 2-s2.0-85053199628 07/03/2018
-
(Quirk BJ, Girotti AW, Whelan HT.) Photomed Laser Surg. 2018 Aug;36(8):397-398 PMID: 30089080 SCOPUS ID: 2-s2.0-85051276856 08/09/2018
-
(Girotti AW.) Lasers Surg Med. 2018 Jul;50(5):590-598 PMID: 29504635 SCOPUS ID: 2-s2.0-85048717513 03/06/2018
-
(Fahey JM, Stancill JS, Smith BC, Girotti AW.) J Biol Chem. 2018 Apr 06;293(14):5345-5359 PMID: 29440272 PMCID: PMC5892570 SCOPUS ID: 2-s2.0-85045064956 02/15/2018
-
(Girotti AW, Korytowski W.) Cell Biochem Biophys. 2017 Dec;75(3-4):413-419 PMID: 28434137 PMCID: PMC5651211 SCOPUS ID: 2-s2.0-85018814813 04/24/2017
-
(Bazak J, Fahey JM, Wawak K, Korytowski W, Girotti AW.) Cancer Cell Microenviron. 2017;4(1) PMID: 29201944 PMCID: PMC5708575 12/05/2017